Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Petr Scherbakov"'
Autor:
Mariam Moshkovskaya, Tatyana Vakhrusheva, Daria Rakitina, Julia Baykova, Oleg Panasenko, Lilia Basyreva, Sergey Gusev, Alexander Gusev, Elena Mikhalchik, Natalia Smolina, Gennadiy Dobretsov, Petr Scherbakov, Asfold Parfenov, Nina Fadeeva, Olga Pobeguts, Vadim Govorun
Publikováno v:
FEBS Open Bio, Vol 10, Iss 3, Pp 414-426 (2020)
Successful colonization of the intestine requires that bacteria interact with the innate immune system and, in particular, neutrophils. Progression of inflammatory bowel diseases (IBD) is associated with alterations in gut microbiota, and dysbiosis i
Externí odkaz:
https://doaj.org/article/b26383d1d4544f44b252c7e0b937492c
Autor:
Elena Mikhalchik, Nadezhda Balabushevich, Tatiana Vakhrusheva, Alexey Sokolov, Julia Baykova, Daria Rakitina, Petr Scherbakov, Sergey Gusev, Alexander Gusev, Zaira Kharaeva, Olga Bukato, Olga Pobeguts
Publikováno v:
FEBS Open Bio, Vol 10, Iss 2, Pp 180-196 (2020)
Bacteria colonizing human intestine adhere to the gut mucosa and avoid the innate immune system. We previously demonstrated that Escherichia coli isolates can adsorb mucin from a diluted solution in vitro. Here, we evaluated the effect of mucin adsor
Externí odkaz:
https://doaj.org/article/c4be7db4be674829b28dba71a8d57182
Autor:
Daria Rakitina, Julia Baikova, Olga Pobeguts, Olga Bukato, Ivan Butenko, Irina Garanina, Mark Levites, Alexander Manolov, Alexandra Kanygina, Elena Kostryukova, Tatiana Semashko, Irina Karpova, Vladislav Babenko, Petr Scherbakov, Igor Khalif, Marina Shapina, Asfold Parfenov, Irina Ruchkina, Oleg Knyazev, Nina Fadeeva, Alexandr Subbotin, Sergey Chamkin, Alexandr Pyrkh, Marina Ivantsova, Vadim Govorun
Publikováno v:
Data in Brief, Vol 23, Iss , Pp - (2019)
One of the dysbioses often observed in Crohn's disease (CD) patients is an increased abundance of Escherichia coli (10–100 fold compared to healthy individuals) (Gevers et al., 2014). The data reported is a large-scale proteome profile for E. coli
Externí odkaz:
https://doaj.org/article/6a2ed077132248669750b38e6d40c583
Autor:
E. V. Mikhalchik, Alexander Gusev, Petr Scherbakov, Gennadiy Dobretsov, Olga Pobeguts, Lilia Basyreva, N A Fadeeva, Oleg M. Panasenko, Julia Baykova, T. V. Vakhrusheva, Vadim M. Govorun, S. A. Gusev, N. V. Smolina, Daria V. Rakitina, A I Parfenov, Mariam Moshkovskaya
Publikováno v:
FEBS Open Bio, Vol 10, Iss 3, Pp 414-426 (2020)
FEBS Open Bio
FEBS Open Bio
Successful colonization of the intestine requires that bacteria interact with the innate immune system and, in particular, neutrophils. Progression of inflammatory bowel diseases (IBD) is associated with alterations in gut microbiota, and dysbiosis i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d53c0f9b68b2466dba58f69c40d3339
https://doaj.org/article/b26383d1d4544f44b252c7e0b937492c
https://doaj.org/article/b26383d1d4544f44b252c7e0b937492c
Autor:
Petr Scherbakov, Tatiana Vakhrusheva, Daria V. Rakitina, Alexey V. Sokolov, Olga Pobeguts, Z. F. Kharaeva, Alexander Gusev, S. A. Gusev, Julia Baykova, Olga Bukato, N. G. Balabushevich, E. V. Mikhalchik
Publikováno v:
FEBS Open Bio
FEBS Open Bio, Vol 10, Iss 2, Pp 180-196 (2020)
FEBS Open Bio, Vol 10, Iss 2, Pp 180-196 (2020)
Bacteria colonizing human intestine adhere to the gut mucosa and avoid the innate immune system. We previously demonstrated that Escherichia coli isolates can adsorb mucin from a diluted solution in vitro. Here, we evaluated the effect of mucin adsor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::080db825c02c2cf6f9db5a0d4cf71b81
https://doi.org/10.1002/2211-5463.12770
https://doi.org/10.1002/2211-5463.12770
Autor:
Julia Baikova, Igor L. Khalif, Mark Levites, Alexandra V. Kanygina, Ivan Butenko, N A Fadeeva, Olga Bukato, E. S. Kostryukova, Oleg Knyazev, Irina Garanina, Alexander I. Manolov, O. V. Pobeguts, Daria V. Rakitina, Vladislav V. Babenko, Marina Ivantsova, Alexandr Pyrkh, Marina V. Shapina, Irina Y. Karpova, Tatiana A. Semashko, Sergey Chamkin, I N Ruchkina, Petr Scherbakov, Alexandr Subbotin, Vadim M. Govorun, A I Parfenov
Publikováno v:
Data in Brief, Vol 23, Iss, Pp-(2019)
Data in Brief
Data in Brief
One of the dysbioses often observed in Crohn's disease (CD) patients is an increased abundance of Escherichia coli (10–100 fold compared to healthy individuals) (Gevers et al., 2014). The data reported is a large-scale proteome profile for E. coli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfbdddb123a2c6ee28bbf0b5130462af
http://www.sciencedirect.com/science/article/pii/S2352340919300836
http://www.sciencedirect.com/science/article/pii/S2352340919300836
Autor:
Igor V. Maev, Vadim M. Govorun, R. K. Ismagilova, Julia Baikova, D N Andreev, Marina V. Shapina, V. G. Ladygina, Sergei Y. Malanin, Irina Y. Karpova, Petr Scherbakov, R B Gorodnichev, Igor L. Khalif, Tatiana A. Semashko, Daria V. Rakitina, Vladislav V. Babenko, Gennady I. Aleshkin, Sofya K. Garushyants, E. S. Kostryukova, Mikhail S. Gelfand, Alexander I. Manolov, Dmitry G. Alexeev, Eugenia S. Lisitsyna, Alexandra V. Kanygina, Andrei K. Larin, Elena N. Ilina
Publikováno v:
BMC Genomics
BMC Genomics, Vol 18, Iss 1, Pp 1-17 (2017)
BMC Genomics, Vol 18, Iss 1, Pp 1-17 (2017)
Background Escherichia coli (E. coli) has been increasingly implicated in the pathogenesis of Crohn’s disease (CD). The phylogeny of E. coli isolated from Crohn’s disease patients (CDEC) was controversial, and while genotyping results suggested h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50c32e0a19cfb332a2a019ca6937ec0f
https://doi.org/10.1186/s12864-017-3917-x
https://doi.org/10.1186/s12864-017-3917-x
Autor:
Oleg Knyazev, Anatolii Konoplyannikov, I N Ruchkina, A I Parfenov, Leonid Lazebnik, V A Rogozina, Petr Scherbakov
Publikováno v:
Gastroenterology. 138:S-571
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6fdf4972f1d92edb2594fccb547f782
https://doi.org/10.1016/s0016-5085(10)62629-7
https://doi.org/10.1016/s0016-5085(10)62629-7